(Q74149696)

English

Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study

scientific article published on 01 January 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457818%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457818%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

R C Urtasun

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457818%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Palmer

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457818%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B Kinney

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457818%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Belch

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457818%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Hewitt

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457818%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Hanson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457818%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457818%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457818%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

40

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457818%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

337-342

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457818%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457818%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900771-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900771-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900771-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900771-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900771-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900771-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900771-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900771-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900771-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxia.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900771-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900771-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900771-2

7 January 2021

based on heuristic

inferred from DOI database lookup

SR 4233: a tumor specific radiosensitizer active in fractionated radiation regimes

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900771-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of the cytotoxicity of SR 4233 to normal and malignant tissues by hypoxic breathing

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900771-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(97)00771-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457818%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9457818%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74149696&oldid=1647839449"